"The
Report Infectious Disease Treatment Market in China 2016-2020
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
About the Infectious Disease
Treatment Market in China
Infectious
diseases are caused by pathogenic microorganisms such as bacteria,
parasites, fungi, or viruses. They can be transmitted from one person
to another through direct or indirect contact. Anti-infective drugs
are used to kill (cidal) or stop the growth (static) of infectious
agents. Based on target organism, anti-infective drugs can be
categorized into antibacterial, antifungal, antiviral, and
antiparasitic.
Technavios
analysts forecast the
Infectious Disease Treatment Market
in China to grow at a CAGR of 5.01% during the period 2016-2020.
Covered in this report
The
report covers the present scenario and the growth prospects of the
infectious disease treatment market in China for 2016-2020. To
calculate the market size, the report considers revenue generated
from the sales of branded, generic, and off-label drugs used to treat
infectious diseases. The report also considers the revenues to be
generated from the sales of drugs that are expected to be launched
into the market along with the decline in revenues from the patent
expiries of the marketed drugs during the forecast period.
Technavio's
report, Infectious Disease Treatment Market in China 2016-2020, has
been prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market.
Download Sample copy of this
Report at
Key vendors
F.
Hoffmann-La Roche
Gilead
Sciences
GSK
Johnson
& Johnson
Merck
Pfizer
Other prominent vendors
Achaogen
Actelion
Adenovir
Pharma
AstraZeneca
Bayer
InSite
Vision
Insmed
Incorporated
KaloBios
Pharmaceuticals
Lytix
Biopharma
Meiji
Seika Pharma
Melinta
Therapeutics
Moberg
Pharma
NanoViricides
NovaBiotics
Ocular
Therapeutix
Panoptes
Pharma
RedHill
Shire
Symbiomix
Tetraphase
Pharmaceuticals
The
Medicines Company
Vertex
Pharmaceuticals
Viamet
Pharmaceuticals
Market driver
Use
of combination therapies
For
a full, detailed list, view our report
Market challenge
Development
of drug resistant strains
For
a full, detailed list, view our report
Market trend
Emergence
of interferon (IFN)-free therapies
For
a full, detailed list, view our report
Read our latest Press
Release at http://www.marketresearchreports.biz/pressreleases
Table of Contents
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Assumptions
Top-vendor offerings
PART 03: Market research
methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: China - An overview
Social and economic conditions
Healthcare reforms
Healthcare infrastructure
PART 06: Opportunities for
global and local vendors
Local vendors
Global vendors
PART 07: Pipeline analysis
AC-170
DEXTENZA
Zerbaxa
Surotomycin
MK-3415A
Amikacin Inhale
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment